Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects

Next Previous
Trial Profile

A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs EQ 101 (Primary)
  • Indications Adult T-cell leukaemia-lymphoma; Alopecia areata; Cutaneous T-cell lymphoma; Large granular lymphocytic leukaemia; T-cell leukaemia
  • Focus Adverse reactions
  • Sponsors Bioniz

Most Recent Events

  • 12 May 2018 Status changed from active, no longer recruiting to completed.
  • 01 May 2018 According to a Bioniz media release, full results will be at the 2018 International Investigative Dermatology Meeting.
  • 01 May 2018 Results presented in a Bioniz Media Release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top